Ventripoint Diagnostics Stock Today

VPTDF Stock  USD 0.17  0.01  5.56%   

Performance

0 of 100

 
Low
 
High
Very Weak

Odds Of Distress

Less than 46

 
100  
 
Zero
About Average
VentriPoint Diagnostics is trading at 0.17 as of the 28th of March 2024. This is a -5.56 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.16. VentriPoint Diagnostics has 46 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. Equity ratings for VentriPoint Diagnostics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of April 2023 and ending today, the 28th of March 2024. Click here to learn more.
Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease worldwide. The company was incorporated in 2004 and is based in Toronto, Canada. Ventripoint Diagnostics is traded on OTC Exchange in the United States.. The company has 156.51 M outstanding shares. More on VentriPoint Diagnostics

Moving against VentriPoint OTC Stock

  0.72EW Edwards Lifesciences Corp Financial Report 24th of April 2024 PairCorr
  0.67ZBH Zimmer Biomet Holdings Financial Report 7th of May 2024 PairCorr
  0.66SYK Stryker Financial Report 6th of May 2024 PairCorr
  0.65BSX Boston Scientific Corp Financial Report 24th of April 2024 PairCorr
  0.56ALGN Align Technology Financial Report 24th of April 2024 PairCorr
  0.47DXCM DexCom Inc Sell-off TrendPairCorr
  0.47VNTN VentureNet CapitalPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

VentriPoint OTC Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. VentriPoint Diagnostics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding VentriPoint Diagnostics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
President CEO, DirectorGeorge Adams
Business ConcentrationMedical Devices, Healthcare (View all Sectors)
VentriPoint Diagnostics [VPTDF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Micro-Cap' category with a current market capitalization of 32.09 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate VentriPoint Diagnostics's market, we take the total number of its shares issued and multiply it by VentriPoint Diagnostics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. VentriPoint Diagnostics classifies itself under Healthcare sector and is part of Medical Devices industry. The entity has 156.51 M outstanding shares. VentriPoint Diagnostics has accumulated about 7.29 M in cash with (3.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05.
Check VentriPoint Diagnostics Probability Of Bankruptcy
Ownership Allocation
VentriPoint Diagnostics maintains a total of 156.51 Million outstanding shares. About 98.0 % of VentriPoint Diagnostics outstanding shares are held by general public with 1.75 (%) owned by insiders and only 0.0 % by institutional holders. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check VentriPoint Ownership Details

VentriPoint Stock Price Odds Analysis

In reference to a normal probability distribution, the odds of VentriPoint Diagnostics jumping above the current price in 90 days from now is under 95%. The VentriPoint Diagnostics probability density function shows the probability of VentriPoint Diagnostics otc stock to fall within a particular range of prices over 90 days. Assuming the 90 days horizon VentriPoint Diagnostics has a beta of 0.6762. This entails as returns on the market go up, VentriPoint Diagnostics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding VentriPoint Diagnostics will be expected to be much smaller as well. Additionally, ventriPoint Diagnostics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming NYSE Composite.
  Odds Below 0.17HorizonTargetOdds Above 0.17
5.02%90 days
 0.17 
94.94%
Based on a normal probability distribution, the odds of VentriPoint Diagnostics to move above the current price in 90 days from now is under 95 (This VentriPoint Diagnostics probability density function shows the probability of VentriPoint OTC Stock to fall within a particular range of prices over 90 days) .

VentriPoint Diagnostics Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. VentriPoint Diagnostics market risk premium is the additional return an investor will receive from holding VentriPoint Diagnostics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in VentriPoint Diagnostics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although VentriPoint Diagnostics' alpha and beta are two of the key measurements used to evaluate VentriPoint Diagnostics' performance over the market, the standard measures of volatility play an important role as well.

VentriPoint Stock Against Markets

Picking the right benchmark for VentriPoint Diagnostics otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in VentriPoint Diagnostics otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for VentriPoint Diagnostics is critical whether you are bullish or bearish towards VentriPoint Diagnostics at a given time. Please also check how VentriPoint Diagnostics' historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in VentriPoint Diagnostics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Bond Analysis Now

   

Bond Analysis

Evaluate and analyze corporate bonds as a potential investment for your portfolios.
All  Next Launch Module

VentriPoint Diagnostics Corporate Directors

VentriPoint Diagnostics corporate directors refer to members of a VentriPoint Diagnostics board of directors. The board of directors generally takes responsibility for the VentriPoint Diagnostics' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of VentriPoint Diagnostics' board members must vote for the resolution. The VentriPoint Diagnostics board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.

How to buy VentriPoint OTC Stock?

Before investing in VentriPoint Diagnostics, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in VentriPoint Diagnostics. To buy VentriPoint Diagnostics stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of VentriPoint Diagnostics. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase VentriPoint Diagnostics stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located VentriPoint Diagnostics stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased VentriPoint Diagnostics stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as VentriPoint Diagnostics, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.

Already Invested in VentriPoint Diagnostics?

The danger of trading VentriPoint Diagnostics is mainly related to its market volatility and OTC Stock specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of VentriPoint Diagnostics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than VentriPoint Diagnostics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile VentriPoint Diagnostics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VentriPoint Diagnostics. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.
Note that the VentriPoint Diagnostics information on this page should be used as a complementary analysis to other VentriPoint Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Complementary Tools for VentriPoint OTC Stock analysis

When running VentriPoint Diagnostics' price analysis, check to measure VentriPoint Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VentriPoint Diagnostics is operating at the current time. Most of VentriPoint Diagnostics' value examination focuses on studying past and present price action to predict the probability of VentriPoint Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VentriPoint Diagnostics' price. Additionally, you may evaluate how the addition of VentriPoint Diagnostics to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Commodity Directory
Find actively traded commodities issued by global exchanges
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Please note, there is a significant difference between VentriPoint Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if VentriPoint Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VentriPoint Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.